Pharmafile Logo
Pharmafocus logo
Advanced Search

Alzhheimer’s

Showing 1 posts of 1 posts found.

Lilly image

EU nod for Lilly brain diagnostic

January 18, 2013
Research and Development, Sales and Marketing Alzhheimer's, Amyvid, brain, lilly

Eli Lilly’s diagnostic radiopharmaceutical Amyvid has been approved in Europe to assess whether patients have Alzheimer’s disease. Amyvid (Florbetapir F …

News
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026